17 participants
Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-15
- Start Date:
- 2021-11-16
- Completion:
- 2022-06-08
Conditions
- Rheumatoid Arthritis
Interventions
- DRUG